Literature DB >> 29201659

Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment.

J Scuffell1, D Boccia2, F Garcia Velarde3, S R Leon3, G Raviola4, L Lecca3,4, J T Galea3,4.   

Abstract

Mental disorders and alcohol/drug use worsen treatment outcomes for multidrug-resistant tuberculosis (TB), but data are lacking for extensively drug-resistant (XDR) TB. We investigated the association of baseline mental disorders and alcohol/drug use on XDR-TB treatment outcomes in a retrospective study of 53 XDR-TB Peruvian patients during 2010-2012. Logistic regression estimated the odds ratios for unfavourable XDR-TB treatment outcomes. Overall treatment success was 25%. Mental disorders and drug/alcohol use were found in respectively 22.4% and 20.4% of patients; neither were associated with unfavourable treatment outcomes. Future research should explore the relationship between mental health and drug/alcohol use in XDR-TB treatment outcomes.

Entities:  

Keywords:  XDR-TB; alcohol; anxiety; depression; psychosis

Year:  2017        PMID： 29201659      PMCID： PMC5677000          DOI： 10.5588/pha.17.0044

Source DB:  PubMed          Journal:  Public Health Action        ISSN： 2220-8372


  6 in total

1.  Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.

Authors:  Molly F Franke; Sasha C Appleton; Jaime Bayona; Fernando Arteaga; Eda Palacios; Karim Llaro; Sonya S Shin; Mercedes C Becerra; Megan B Murray; Carole D Mitnick
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

2.  Depression: a silent driver of the global tuberculosis epidemic.

Authors:  Annika Sweetland; Maria Oquendo; Priya Wickramaratne; Myrna Weissman; Milton Wainberg
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.

Authors:  I F Walker; S C Baral; X Wei; R Huque; A Khan; J Walley; J N Newell; H Elsey
Journal:  Int J Tuberc Lung Dis       Date:  2017-06-01       Impact factor: 2.373

4.  Psychosocial support groups for patients with multidrug-resistant tuberculosis: five years of experience.

Authors:  J Acha; A Sweetland; D Guerra; K Chalco; H Castillo; E Palacios
Journal:  Glob Public Health       Date:  2007

5.  Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.

Authors:  P Vega; A Sweetland; J Acha; H Castillo; D Guerra; M C Smith Fawzi; S Shin
Journal:  Int J Tuberc Lung Dis       Date:  2004-06       Impact factor: 2.373

Review 6.  A review of the interplay between tuberculosis and mental health.

Authors:  Anne M Doherty; John Kelly; Colm McDonald; Anne Marie O'Dywer; Joseph Keane; John Cooney
Journal:  Gen Hosp Psychiatry       Date:  2013-05-06       Impact factor: 3.238
  6 in total
  6 in total

1.  Mental disease, alcoholism and XDR-TB: loss to follow-up and resistance, the cost of an inadequate approach.

Authors:  Ignacio Monedero
Journal:  Public Health Action       Date:  2017-09-21

2.  Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis.

Authors:  G Lee; J Scuffell; J T Galea; S S Shin; E Magill; E Jaramillo; A C Sweetland
Journal:  Int J Tuberc Lung Dis       Date:  2020-12-01       Impact factor: 2.373

3.  Mental Health Status and Its Impact on TB Treatment and Its Outcomes: A Scoping Literature Review.

Authors:  Charles Kwaku Agbeko; Manthar Ali Mallah; Biyu He; Qiao Liu; Huan Song; Jianming Wang
Journal:  Front Public Health       Date:  2022-05-31

Review 4.  Comorbidities between tuberculosis and common mental disorders: a scoping review of epidemiological patterns and person-centred care interventions from low-to-middle income and BRICS countries.

Authors:  André Janse Van Rensburg; Audry Dube; Robyn Curran; Fentie Ambaw; Jamie Murdoch; Max Bachmann; Inge Petersen; Lara Fairall
Journal:  Infect Dis Poverty       Date:  2020-01-15       Impact factor: 4.520

5.  Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.

Authors:  Chinmay Laxmeshwar; Mrinalini Das; Taanya Mathur; Tarun Israni; Santosh Jha; Aparna Iyer; Mabel Morales; Tom Decroo; Tinne Gils; Gabriella Ferlazzo; Kleio Iakovidi; Mariana Garcia; Petros Isaakidis
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

6.  [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].

Authors:  Nelly Tatés-Ortega; Jorge Álvarez; Lucelly López; Alberto Mendoza-Ticona; Edith Alarcón-Arrascue
Journal:  Rev Panam Salud Publica       Date:  2019-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.